Sign in

CIK 0001755237

  • Non-accelerated filer
  • Smaller reporting company

Korsana Biosciences, Inc.

Sign in to watch
Ticker
KRSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
831895370
Phone
+1 781-516-2325
Business address
203 CRESCENT STREET, BLDGS. #3/3A/4, SUITE 503, WALTHAM, MA, 02453
Former names
Cyclerion Therapeutics, Inc.
  1. 4 Open-market buy 10% owner bought 961,538 shares at $3.12 ($2,999,999)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market buy Chief Executive Officer bought 302,000 shares at $2.43 ($733,860)
  4. 4 Open-market buy Chief Executive Officer bought 698,001 shares at an average $2.43 ($1,693,943)
  5. 4 Open-market sale Chief Financial Officer sold 1,824 shares at $4.00 ($7,296)
  6. 4 Open-market sale Chief Medical Officer sold 2,637 shares at $3.99 ($10,522)
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market sale President and CSO sold 20,107 shares at $3.01 ($60,522)
  11. 4 Open-market buy Chief Innovation Officer bought 125,000 shares at $2.53 ($316,250)
  12. 4 Open-market sale Chief Financial Officer sold 3,827 shares at $2.52 ($9,644)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 4 of 7 · 134 filings